Kailera Therapeutics, Inc. (KLRA) Earnings History

Quarterly EPS Results — source: SEC EDGAR

Quarter	EPS Estimate	EPS Actual	Surprise	Result
Q22026 FY2026	$-0.74	—	—	Miss
Q12026 FY2026	—	$3650.00	—	Miss

Back to KLRA overview · KLRA holders · KLRA KPIs

Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.